✦ LIBER ✦

Endometrial cancer risk in estrogen users after switching to estrogen–progestin therapy

✍ Scribed by Jessica Chubak; Jennifer A. Doherty; Kara L. Cushing-Haugen; Lynda F. Voigt; Babette S. Saltzman; Deirdre A. Hill; Shirley A. A. Beresford; Noel S. Weiss

Publisher: Springer Netherlands
Year: 2007
Tongue: English
Weight: 149 KB
Volume: 18
Category: Article
ISSN: 0957-5243
DOI: 10.1007/s10552-007-9040-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term use of continuous-combined est

Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer

✍ Amanda I. Phipps; Jennifer A. Doherty; Lynda F. Voigt; Deirdre A. Hill; Shirley 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 181 KB

Unopposed estrogen and estrogen plus pro

Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort

✍ Louise A. Brinton; Lauren Schwartz; Margaret R. Spitz; Yikyung Park; Albert R. H 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 208 KB